Regeneron vows ‘vigorous’ defense against allegations it paid kickbacks for eye drug

Regeneron vows ‘vigorous’ defense against allegations it paid kickbacks for eye drug

Source: 
MedCity News
snippet: 

The U.S. district attorney for Massachusetts filed suit against the drugmaker this week, alleging that it paid tens of millions in kickbacks through a copay foundation for Eylea, a drug used to treat macular degeneration.